Pharming Group

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.

CEO

Fabrice Chouraqui

CEOFabrice Chouraqui

Employees

—

Employees—

Headquarters

Leiden, Zuid-Holland

HeadquartersLeiden, Zuid-Holland

Founded

2019

Founded2019

Employees

—

Employees—

PHAR Key Statistics

Market cap

544.25M

Market cap544.25M

Price-Earnings ratio

-48.78

Price-Earnings ratio-48.78

Dividend yield

—

Dividend yield—

Average volume

6.64K

Average volume6.64K

High today

$8.52

High today$8.52

Low today

$8.00

Low today$8.00

Open price

$8.52

Open price$8.52

Volume

6.88K

Volume6.88K

52 Week high

$11.07

52 Week high$11.07

52 Week low

$6.65

52 Week low$6.65

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

Pharming Group

Why Robinhood?

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. Show more

PHAR Key Statistics

Analyst ratings

100%

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.